Literature DB >> 33753211

LINC01614 promotes osteosarcoma progression via miR-520a-3p/SNX3 axis.

Qixuan Cai1, Xin Zhao2, Yanbing Wang2, Shuai Li1, Jincheng Wang2, Zhuoyuan Xin3, Fan Li4.   

Abstract

Long noncoding RNAs (lncRNAs) have been reported as essential regulators in osteosarcoma (OS), the most malignant bone tumor usually observed in children and adolescents. In the present study, we detected differentially expressed lncRNAs among OS tissues through RNA-sequencing. Then through bioinformatics analysis, we constructed the aberrant lncRNAs regulatory networks, and detected the key-lncRNAs. We identified LINC01614 was most significantly up-regulated among OS tissues, which was positively correlated with the worse prognosis. Through related in vitro experiments, we confirmed that knockdown of LINC01614 could inhibit the proliferation, invasion, and metastasis activities of OS cells. Furthermore, we identified LINC01614 may promote the proliferation and invasion activities of OS cells, via binding miR-520a-3p and increase the expression of SNX3. In conclusion, we identified lncRNAs participate in various malignant behaviors in OS. We also proved that LINC01614 could function as competing endogenous RNAs and promote the proliferation, and invasion of OS cells through miR-520a-3p/SNX3 axis, and thus acts as a novel prognostic marker for OS in clinic.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  LINC01614; Osteosarcoma; Regulatory network; ceRNA; miR-520a-3p

Mesh:

Substances:

Year:  2021        PMID: 33753211     DOI: 10.1016/j.cellsig.2021.109985

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  7 in total

Review 1.  LncRNA MALAT1-related signaling pathways in osteosarcoma.

Authors:  Maryam Farzaneh; Sajad Najafi; Omid Anbiyaee; Shirin Azizidoost; Seyed Esmaeil Khoshnam
Journal:  Clin Transl Oncol       Date:  2022-07-06       Impact factor: 3.340

2.  A Newly Established Cuproptosis-Associated Long Non-Coding RNA Signature for Predicting Prognosis and Indicating Immune Microenvironment Features in Soft Tissue Sarcoma.

Authors:  Jun Han; Yunxiang Hu; Sanmao Liu; Jian Jiang; Hong Wang
Journal:  J Oncol       Date:  2022-07-06       Impact factor: 4.501

3.  Revealing the Role of lncRNA CCDC144NL-AS1 and LINC01614 in Gastric Cancer via Integrative Bioinformatics Analysis and Experimental Validation.

Authors:  Weiwei Sheng; Weihong Zhou; Yundi Cao; Yuejiao Zhong
Journal:  Front Oncol       Date:  2022-01-10       Impact factor: 6.244

4.  Ferroptosis‑related long non‑coding RNAs and the roles of LASTR in stomach adenocarcinoma.

Authors:  Gongjun Wang; Libin Sun; Shasha Wang; Jing Guo; Ruoxi Xiao; Wenqian Li; Weiwei Qi; Wensheng Qiu
Journal:  Mol Med Rep       Date:  2022-02-09       Impact factor: 2.952

5.  Bioinformatics analysis of lncRNAs in the occurrence and development of osteosarcoma.

Authors:  Hua Liu; Chenyu Zong; Jiacheng Sun; Haiyang Li; Guangzhen Qin; Xiaojian Wang; Jianwei Zhu; Yang Yang; Qiang Xue; Xianchen Liu
Journal:  Transl Pediatr       Date:  2022-07

6.  Long non‑coding RNA 01614 hyperactivates WNT/β‑catenin signaling to promote pancreatic cancer progression by suppressing GSK‑3β.

Authors:  Long-Jiang Chen; Lun Wu; Wei Wang; Lu-Lu Zhai; Feng Xiang; Wei-Bo Li; Zhi-Gang Tang
Journal:  Int J Oncol       Date:  2022-08-05       Impact factor: 5.884

7.  Identifying glycolysis-related LncRNAs for predicting prognosis in breast cancer patients.

Authors:  Jiayue Zou; Yanlin Gu; Qi Zhu; Xiaohua Li; Lei Qin
Journal:  Cancer Biomark       Date:  2022       Impact factor: 3.828

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.